Delisting Determination, The Nasdaq Stock Market, LLC,
January 25, 2022,  Odonate Therapeutics, Inc.
The Nasdaq Stock Market LLC (the Exchange) has determined
to remove from listing the common stock of Odonate
Therapeutics, Inc. (the Company), effective at the
opening of the trading session on February 4, 2022.
Based on review of information provided by the Company,
Nasdaq Staff determined that the Company no longer
qualified for listing on the Exchange pursuant to
Listing Rule 5101. The Company was notified of the Staff
determination on January 6, 2022. The Company did not appeal
the Staff determination to the Hearings Panel. The Company
securities were suspended on January 18, 2022. The Staff
determination to delist the Company common stock became
final on January 18, 2022.